These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 21519331

  • 1. c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat.
    Han Y, Ma FY, Tesch GH, Manthey CL, Nikolic-Paterson DJ.
    Lab Invest; 2011 Jul; 91(7):978-91. PubMed ID: 21519331
    [Abstract] [Full Text] [Related]

  • 2. Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat.
    Ma FY, Flanc RS, Tesch GH, Bennett BL, Friedman GC, Nikolic-Paterson DJ.
    Lab Invest; 2009 Apr; 89(4):470-84. PubMed ID: 19188913
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinase-12 deficiency attenuates experimental crescentic anti-glomerular basement membrane glomerulonephritis.
    Abraham AP, Ma FY, Mulley WR, Nikolic-Paterson DJ, Tesch GH.
    Nephrology (Carlton); 2018 Feb; 23(2):183-189. PubMed ID: 27862656
    [Abstract] [Full Text] [Related]

  • 4. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.
    Nishikawa K, Guo YJ, Miyasaka M, Tamatani T, Collins AB, Sy MS, McCluskey RT, Andres G.
    J Exp Med; 1993 Mar 01; 177(3):667-77. PubMed ID: 8094735
    [Abstract] [Full Text] [Related]

  • 5. Role of macrophages in the fibrotic phase of rat crescentic glomerulonephritis.
    Han Y, Ma FY, Tesch GH, Manthey CL, Nikolic-Paterson DJ.
    Am J Physiol Renal Physiol; 2013 Apr 15; 304(8):F1043-53. PubMed ID: 23408165
    [Abstract] [Full Text] [Related]

  • 6. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
    Isome M, Fujinaka H, Adhikary LP, Kovalenko P, El-Shemi AG, Yoshida Y, Yaoita E, Takeishi T, Takeya M, Naito M, Suzuki H, Yamamoto T.
    Nephrol Dial Transplant; 2004 Dec 15; 19(12):2997-3004. PubMed ID: 15574997
    [Abstract] [Full Text] [Related]

  • 7. An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis.
    Han Y, Ma FY, Di Paolo J, Nikolic-Paterson DJ.
    Int J Immunopathol Pharmacol; 2018 Dec 15; 32():2058738418783404. PubMed ID: 29923438
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats.
    Chadban SJ, Tesch GH, Lan HY, Atkins RC, Nikolic-Paterson DJ.
    Kidney Int; 1997 Jun 15; 51(6):1809-17. PubMed ID: 9186870
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats.
    Takeda S, Takahashi M, Sado Y, Takeuchi K, Hakamata Y, Shimizu H, Kaneko T, Yamamoto H, Ito C, Ookawara S, Asano Y, Kusano E, Kobayashi E.
    Nephrol Dial Transplant; 2004 Sep 15; 19(9):2228-36. PubMed ID: 15238626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.